These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 14644827

  • 1. Oral contraceptives and reproductive system cancer.
    Deligeoroglou E, Michailidis E, Creatsas G.
    Ann N Y Acad Sci; 2003 Nov; 997():199-208. PubMed ID: 14644827
    [Abstract] [Full Text] [Related]

  • 2. [Combined oral contraception and the risk of reproductive organs cancer in women].
    Medard M L, Ostrowska L.
    Ginekol Pol; 2007 Aug; 78(8):637-41. PubMed ID: 18050614
    [Abstract] [Full Text] [Related]

  • 3. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
    Iversen L, Fielding S, Lidegaard Ø, Mørch LS, Skovlund CW, Hannaford PC.
    BMJ; 2018 Sep 26; 362():k3609. PubMed ID: 30257920
    [Abstract] [Full Text] [Related]

  • 4. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
    Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER.
    Cancer Epidemiol Biomarkers Prev; 2013 Nov 26; 22(11):1931-43. PubMed ID: 24014598
    [Abstract] [Full Text] [Related]

  • 5. Cancers in Australia in 2010 attributable to and prevented by the use of combined oral contraceptives.
    Jordan SJ, Wilson LF, Nagle CM, Green AC, Olsen CM, Bain CJ, Pandeya N, Whiteman DC, Webb PM.
    Aust N Z J Public Health; 2015 Oct 26; 39(5):441-5. PubMed ID: 26437729
    [Abstract] [Full Text] [Related]

  • 6. Combined oral contraceptives: risks and benefits.
    Thorogood M, Villard-Mackintosh L.
    Br Med Bull; 1993 Jan 26; 49(1):124-39. PubMed ID: 8324603
    [Abstract] [Full Text] [Related]

  • 7. The combined oral contraceptive. Risks and adverse effects in perspective.
    Bagshaw S.
    Drug Saf; 1995 Feb 26; 12(2):91-6. PubMed ID: 7766340
    [Abstract] [Full Text] [Related]

  • 8. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
    Urban M, Banks E, Egger S, Canfell K, O'Connell D, Beral V, Sitas F.
    PLoS Med; 2012 Feb 26; 9(3):e1001182. PubMed ID: 22412354
    [Abstract] [Full Text] [Related]

  • 9. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB, Porterfield D.
    Contraception; 1992 Feb 26; 45(2):93-104. PubMed ID: 1559340
    [Abstract] [Full Text] [Related]

  • 10. Oral contraceptives and cancer.
    Holck S, Ebeling K.
    Arch Geschwulstforsch; 1986 Feb 26; 56(2):155-67. PubMed ID: 3518652
    [Abstract] [Full Text] [Related]

  • 11. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
    Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC.
    Am J Obstet Gynecol; 2017 Jun 26; 216(6):580.e1-580.e9. PubMed ID: 28188769
    [Abstract] [Full Text] [Related]

  • 12. Oral contraception and cancer of the female reproductive system.
    Woods KL.
    J Clin Hosp Pharm; 1985 Jun 26; 10(2):123-35. PubMed ID: 3894428
    [Abstract] [Full Text] [Related]

  • 13. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E, Malone KE, Weiss NS, Daling JR.
    J Natl Cancer Inst; 1994 Apr 06; 86(7):505-14. PubMed ID: 8133534
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Health outcomes associated with use of hormonal contraception: breast cancer.
    Schneyer R, Lerma K.
    Curr Opin Obstet Gynecol; 2018 Dec 06; 30(6):414-418. PubMed ID: 30239373
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
    Maxwell GL, Schildkraut JM, Calingaert B, Risinger JI, Dainty L, Marchbanks PA, Berchuck A, Barrett JC, Rodriguez GC.
    Gynecol Oncol; 2006 Nov 06; 103(2):535-40. PubMed ID: 16740300
    [Abstract] [Full Text] [Related]

  • 19. [Use of oral contraceptives and risk of cancer, a cohort study].
    Kumle M, Alsaker E, Lund E.
    Tidsskr Nor Laegeforen; 2003 Jun 12; 123(12):1653-6. PubMed ID: 12821980
    [Abstract] [Full Text] [Related]

  • 20. The combined oral contraceptive pill in women over age forty.
    Wong MT, Singh K.
    Ann Acad Med Singap; 2003 Sep 12; 32(5):624-31. PubMed ID: 14626790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.